More importantly, our investigation reveals that high expression levels of KSR2 and 14–3-3ζ are significantly correlated with tumor growth and serve as independent prognostic factors for the poor outcomes of HCC patients. This evidence concerns the gene KSR2 and hepatocellular carcinoma.